Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

17.00
-0.6700-3.79%
Post-market: 17.100.1000+0.59%19:56 EDT
Volume:3.53M
Turnover:60.47M
Market Cap:3.31B
PE:-33.95
High:18.04
Open:17.86
Low:16.86
Close:17.67
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:1.24
T/O Rate:3.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:2.69
PE(LYR):-10.49

Loading ...

Legend Biotech Corp : Raymond James Cuts Target Price to $58 from $86

THOMSON REUTERS
·
Jul 28

Legend Biotech Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
Jul 28

Buy Rating Reiterated as Strong CARVYKTI Momentum and Attractive Valuation Support Unchanged $65 Price Target

TIPRANKS
·
Jul 28

Under the Radar: Legend Stock Tumbles After CEO's Abrupt Departure

Dow Jones
·
Jul 28

Legend Biotech's In Vivo CAR-T Cell Therapy Data Validates Approach, RBC Capital Markets Says

MT Newswires Live
·
Jul 27

Legend Biotech is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 27

Legend Biotech falls -12.5%

TIPRANKS
·
Jul 27

Legend Biotech price target lowered to $59 from $63 at RBC Capital

TIPRANKS
·
Jul 27

RBC Cuts Price Target on Legend Biotech to $59 From $63, Keeps Outperform Rating

MT Newswires Live
·
Jul 27

Legend Biotech Shares Down 3.7% Premarket; Ying Huang Steps Down as CEO and Board Member, Alan Bash Appointed Interim CEO

THOMSON REUTERS
·
Jul 27

Legend Biotech Names Alan Bash Interim CEO After Ying Huang Resigns

Reuters
·
Jul 27

Legend Biotech Corp - Ying Huang Steps Down as CEO and Board Member; to Remain as Advisor Through August

THOMSON REUTERS
·
Jul 27

Legend Biotech Corp - Alan Bash Appointed Interim CEO

THOMSON REUTERS
·
Jul 27

Legend Biotech Corp - Board Initiates Search for Permanent CEO Successor

THOMSON REUTERS
·
Jul 27

Legend Biotech Announces CEO Transition

THOMSON REUTERS
·
Jul 27

Legend Biotech Shares Fall After UBS Downgrade

MT Newswires Live
·
Jul 25

Legend Biotech Cut to Neutral from Buy by UBS

Dow Jones
·
Jul 24

UBS Downgrades Legend Biotech to Neutral From Buy, Adjusts Price Target to $28 From $49

MT Newswires Live
·
Jul 24

Legend Biotech downgraded to Neutral from Buy at UBS

TIPRANKS
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Legend Biotech (LEGN) and AngioDynamics (ANGO)

TIPRANKS
·
Jul 16